1-(3-(2-(BENZO[B]THIOPHEN-5-YL)ETHOXY)PROPYL)AZETIDIN-3-OL, 95.0%, 50mg

2,2,2-Trifluoroethyl formate, 95.0%, 25g

(S)-1-Boc-2-butyl-piperazine, 97%, 10g

2-Amino-6-(trifluoromethyl)benzothiazole, 98.0%, 5g

8-Chloro-2-methylimidazo[1,2-a]pyridine, 98%, 250mg

4-Bromo-1-methyl-1H-pyrazole-5-carboxylic acid, 95.0%, 25g

Sodium 2-iodobenzenesulfonate, 97%, 100g

Methyl (S)-4-(pyrrolidin-2-yl)benzoate hydrochloride, 95% HPLC, 1g

D(+)-Mannose, ≥99.5%, for biochemistry, 50 g, plastic packaging.

2,4-Dimethyl-3-nitropyridine, 97.0%, 5g

4-Cyanopyridine-N-oxide, 95.0%, 50g

tert-Butyl ((3S,4R)-4-aminotetrahydrofuran-3-yl)carbamate, 97%, 500mg

(R)-1-(3-Nitro-5-(trifluoromethyl)phenyl)ethan-1-amine hydrochloride, 98%, 5g